Literature DB >> 25754320

Renal Denervation in Heart Failure.

Michael W Fong1, David Shavelle, Fred A Weaver, Mitra K Nadim.   

Abstract

Heart failure has emerged as one of the most important diseases of the past century. The understanding and treatment of heart failure has evolved significantly over the years. As we move further into the era of device therapy, attention has turned to the idea of sympathetic nervous system modulation through renal denervation to treat heart failure. In this review, we summarize the background research, denervation technique, and current studies on renal denervation for the treatment of heart failure. We also compare and contrast the work on carotid barostimulation.

Entities:  

Mesh:

Year:  2015        PMID: 25754320     DOI: 10.1007/s11906-014-0528-7

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  41 in total

1.  Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure.

Authors:  Jay Ritzema; Richard Troughton; Iain Melton; Ian Crozier; Robert Doughty; Henry Krum; Anthony Walton; Philip Adamson; Saibal Kar; Prediman K Shah; Mark Richards; Neal L Eigler; James S Whiting; Garrie J Haas; J Thomas Heywood; Christopher M Frampton; William T Abraham
Journal:  Circulation       Date:  2010-02-22       Impact factor: 29.690

Review 2.  Functional role of renal afferents.

Authors:  A Stella; A Zanchetti
Journal:  Physiol Rev       Date:  1991-07       Impact factor: 37.312

3.  Chronic electrical stimulation of the carotid sinus baroreflex improves left ventricular function and promotes reversal of ventricular remodeling in dogs with advanced heart failure.

Authors:  Hani N Sabbah; Ramesh C Gupta; Makoto Imai; Eric D Irwin; Sharad Rastogi; Martin A Rossing; Robert S Kieval
Journal:  Circ Heart Fail       Date:  2010-11-19       Impact factor: 8.790

4.  Effects of renal denervation on postprandial sodium excretion in experimental heart failure.

Authors:  D Villarreal; R H Freeman; R A Johnson; J C Simmons
Journal:  Am J Physiol       Date:  1994-05

5.  Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial.

Authors:  William T Abraham; Philip B Adamson; Robert C Bourge; Mark F Aaron; Maria Rosa Costanzo; Lynne W Stevenson; Warren Strickland; Suresh Neelagaru; Nirav Raval; Steven Krueger; Stanislav Weiner; David Shavelle; Bradley Jeffries; Jay S Yadav
Journal:  Lancet       Date:  2011-02-19       Impact factor: 79.321

Review 6.  Endothelin in cardiovascular disease: from atherosclerosis to heart failure.

Authors:  P J Best; A Lerman
Journal:  J Cardiovasc Pharmacol       Date:  2000       Impact factor: 3.105

Review 7.  Chronic baroreflex activation: a potential therapeutic approach to heart failure with preserved ejection fraction.

Authors:  Dimitrios Georgakopoulos; William C Little; William T Abraham; Fred A Weaver; Michael R Zile
Journal:  J Card Fail       Date:  2010-10-29       Impact factor: 5.712

8.  Catheter-based renal denervation for resistant hypertension: 12-month results of the EnligHTN I first-in-human study using a multielectrode ablation system.

Authors:  Vasilios Papademetriou; Costas P Tsioufis; Ajay Sinhal; Derek P Chew; Ian T Meredith; Yuvi Malaiapan; Matthew I Worthley; Stephen G Worthley
Journal:  Hypertension       Date:  2014-06-16       Impact factor: 10.190

9.  Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.

Authors:  Hans L Hillege; Dorothea Nitsch; Marc A Pfeffer; Karl Swedberg; John J V McMurray; Salim Yusuf; Christopher B Granger; Eric L Michelson; Jan Ostergren; Jan Hein Cornel; Dick de Zeeuw; Stuart Pocock; Dirk J van Veldhuisen
Journal:  Circulation       Date:  2006-02-07       Impact factor: 29.690

10.  Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study.

Authors:  Edoardo Gronda; Gino Seravalle; Gianmaria Brambilla; Giuseppe Costantino; Andrea Casini; Ali Alsheraei; Eric G Lovett; Giuseppe Mancia; Guido Grassi
Journal:  Eur J Heart Fail       Date:  2014-07-28       Impact factor: 15.534

View more
  4 in total

1.  Raising the Bar in Renal Sympathetic Denervation Research and Reporting.

Authors:  John Lee; J Rick Turner
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-09-15       Impact factor: 3.738

2.  Renal Denervation Reduces Pulmonary Vascular Remodeling and Right Ventricular Diastolic Stiffness in Experimental Pulmonary Hypertension.

Authors:  Denielli da Silva Gonçalves Bos; Chris Happé; Ingrid Schalij; Wioletta Pijacka; Julian F R Paton; Christophe Guignabert; Ly Tu; Raphaël Thuillet; Harm-Jan Bogaard; Albert C van Rossum; Anton Vonk-Noordegraaf; Frances S de Man; M Louis Handoko
Journal:  JACC Basic Transl Sci       Date:  2017-02-01

3.  Renal denervation attenuates aldosterone expression and associated cardiovascular pathophysiology in angiotensin II-induced hypertension.

Authors:  Mo-Na Hong; Xiao-Dong Li; Dong-Rui Chen; Cheng-Chao Ruan; Jian-Zhong Xu; Jing Chen; Yong-Jie Wu; Yu Ma; Ding-Liang Zhu; Ping-Jin Gao
Journal:  Oncotarget       Date:  2016-10-18

Review 4.  Neurohormonal modulation in pulmonary arterial hypertension.

Authors:  Eva L Peters; Harm Jan Bogaard; Anton Vonk Noordegraaf; Frances S de Man
Journal:  Eur Respir J       Date:  2021-10-28       Impact factor: 16.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.